Targeted Therapies for Autoimmune Bullous Diseases: Current Status Kyle T. AmberRoberto MaglieMichael Hertl Leading Article 20 September 2018 Pages: 1527 - 1548
Therapeutic Advances and Challenges in the Treatment of Progressive Multiple Sclerosis Laura E. BaldassariRobert J. Fox Review Article 25 September 2018 Pages: 1549 - 1566
Cardiovascular Safety of Antihyperglycemic Agents: “Do Good or Do No Harm” Antonis A. ManolisTheodora A. ManolisAntonis S. Manolis Review Article 24 September 2018 Pages: 1567 - 1592
Antibiotics and Cure Rates in Childhood Febrile Urinary Tract Infections in Clinical Trials: A Systematic Review and Meta-analysis Konstantinos VazourasRomain BasmaciYingfen Hsia Systematic Review 11 October 2018 Pages: 1593 - 1604
Sodium Zirconium Cyclosilicate: A Review in Hyperkalaemia Sheridan M. Hoy Adis Drug Evaluation Open access 10 October 2018 Pages: 1605 - 1613
Dinoprostone Vaginal Insert: A Review in Cervical Ripening Matt Shirley Adis Drug Evaluation 13 October 2018 Pages: 1615 - 1624
Patisiran: First Global Approval Sheridan M. Hoy AdisInsight Report 24 September 2018 Pages: 1625 - 1631
Lanadelumab: First Global Approval Yahiya Y. Syed AdisInsight Report 28 September 2018 Pages: 1633 - 1637
Caplacizumab: First Global Approval Sean Duggan AdisInsight Report Open access 08 October 2018 Pages: 1639 - 1642
Doravirine: First Global Approval Emma D. Deeks AdisInsight Report 19 October 2018 Pages: 1643 - 1650
Correction to: Delafloxacin: First Global Approval Anthony Markham Correction Open access 04 October 2018 Pages: 1651 - 1651